Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 166 to 180 of 352 results for depression

  1. Patient group directions (MPG2)

    This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.

    Medicines practice guideline
    Last updated
    27 March 2017
    View recommendations

    Sections for MPG2

  2. Minimally invasive video‑assisted parathyroidectomy (IPG501)

    Evidence-based recommendations on minimally invasive video-assisted parathyroidectomy. This involves inserting surgical instruments through a small cut (keyhole surgery) to find and remove any abnormal glands.

    Interventional procedures guidance
    Published
    23 August 2014
    View recommendations

    Sections for IPG501

  3. How effective and cost effective are different types of exercise referral scheme? Compare the relative effects of different models in controlled studies. Include health-related quality of life as an outcome. Compare exercise referral schemes that vary by: - setting – for example, home-based, gym-based, community-based or outdoors - intensity and duration – for example, a 12-week scheme involving 1 session a week, or a 6-week scheme involving 4 1-hour sessions per week - the techniques used, for example, some use additional 'supportive' techniques such as 'motivational interviewing' and education sessions - the target group, for example, people who are overweight and obese, people with raised blood pressure or cholesterol levels or those experiencing mild depression, anxiety or stress; or by age, gender, race or socioeconomic status - other scheme characteristics including: design, content and delivery; referral mechanisms; choice of activity; cost and qualifications of instructors; and whether it is commissioned and delivered by an NHS, non-NHS or community-based organisation.

    raised blood pressure or cholesterol levels or those experiencing mild depression, anxiety or stress; or by age, gender, race or...

    Research recommendation
    Published
    9 June 2015

  4. Ustekinumab for treating moderately to severely active ulcerative colitis (TA633)

    Evidence-based recommendations on ustekinumab (Stelara) for treating moderately to severely active ulcerative colitis in adults.

    Technology appraisal guidance
    Published
    17 June 2020
    View recommendations

    Sections for TA633

  5. Drug misuse in over 16s: opioid detoxification (CG52)

    This guideline covers helping adults and young people over 16 who are dependent on opioids to stop using drugs. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

    Clinical guideline
    Published
    25 July 2007
    View recommendations

    Sections for CG52

  6. Learning disability: identifying and managing mental health problems (QS142)

    This quality standard covers the prevention, assessment and management of mental health problems in people with learning disabilities in all settings (including health, social care, education, and forensic and criminal justice). It also covers family members, carers and care workers.

    Quality standard
    Published
    10 January 2017
    View quality statements

    Sections for QS142

  7. Lung cancer: diagnosis and management (NG122)

    This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up.

    NICE guideline
    Last updated
    8 March 2024

    Sections for NG122

  8. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    activity in reducing anxiety symptoms is substantially smaller than that for depression. However, where evidence exists there are signs...

    Research recommendation
    Published
    9 June 2015

  9. Parkinson's disease (QS164)

    This quality standard covers the management of Parkinson’s disease in adults. It does not include treatment of parkinsonism not caused by Parkinson’s disease. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    9 February 2018
    View quality statements

    Sections for QS164

  10. Endometrial cryotherapy for menorrhagia (IPG157)

    Evidence-based recommendations on endometrial cryotherapy for menorrhagia (heavy periods). This involves using cold temperatures to freeze and destroy the lining of the womb.

    Interventional procedures guidance
    Published
    22 March 2006
    View recommendations

    Sections for IPG157

  11. Older people: independence and mental wellbeing (NG32)

    This guideline covers interventions to maintain and improve the mental wellbeing and independence of people aged 65 or older and how to identify those most at risk of a decline.

    NICE guideline
    Published
    17 December 2015
    View recommendations

    Sections for NG32

  12. 'Walking across' from one assessment instrument to another:- What methodology should be used to allow 'walking across' from one assessment instrument for common mental health disorders to another?

    Why is this important?:- A number of different ratings scales for depression and anxiety disorders are in current use, both in research...

    Research recommendation
    Published
    9 June 2015

  13. Psychological support needs:- A qualitative study should be undertaken to evaluate information and support interventions to address psychological needs at different points in the care pathway for people with pancreatic cancer.

    that impact on their quality of life. These can be related to anxiety and depression, and to the psychological impact of fatigue, pain,...

    Research recommendation
    Published
    14 November 2018

  14. Cabozantinib for previously treated advanced hepatocellular carcinoma (TA849)

    Evidence-based recommendations on cabozantinib (Cabometyx) for advanced hepatocellular carcinoma in adults who have had sorafenib.

    Technology appraisal guidance
    Published
    14 December 2022
    View recommendations

    Sections for TA849

  15. Psychological assessment:- What is the most effective measure of psychological functioning to use as a test for thresholds of concern in people with cystic fibrosis?

    and these would be useful to validate generic measures (for example for depression and anxiety). People with a long-term physical health...

    Research recommendation
    Published
    18 October 2018